Synopsis
This consensus statement is an update to the 2010 position on exercise and type 2 diabetes (T2D) published jointly by the American College of Sports Medicine (ACSM) and the American Diabetes Association (ADA). In the following decade, published a considerable amount of research on select topics related to exercise in people of different ages with T2D, while the prevalence of diabetes continued to expand worldwide.
The goal of this consensus statement is to provide readers with a summary of the current evidence and to expand and update previous recommendations from 2010. The writing group used a consensus approach to synthesize available evidence from clinical trials and case reports, narrative and systematic reviews, and meta-analyses, and the recommendations represent the consensus of the writing panel and the ACSM and incorporate guidance from other professional organizations with expertise in this area, such as the ADA.
Current science, new discussion topics, and clinical experience in making recommendations for the participation of people with T2D of all ages are highlighted. Additionally, the title of the consensus statement and the text itself have been expanded to include physical activity (PA), a broader and more comprehensive definition of human movement of which structured or planned exercise is a subset.
People with type 2 diabetes should engage in regular physical activity and should be encouraged to reduce sedentary time and break up sitting time with frequent activity breaks. Any activity performed with acute and chronic diabetes-related health complications may require accommodations to ensure safe and effective participation. Other topics addressed include exercise time to maximize its glucose-lowering effects and barriers and inequalities in the adoption and maintenance of physical activity.
Diabetes currently affects more than 463 million people worldwide (3), and its prevalence in the United States is 10.5% (4). T2D accounts for 90% to 95% of all cases. The goal of treatment for T2D is to facilitate an individualized treatment plan, which may include education, glycemic control, cardiovascular disease (CVD) risk reduction, and ongoing screening for microvascular complications, to achieve and maintain optimal blood glucose levels. blood, lipids and blood pressure levels that prevent or delay chronic complications.
Lifestyle interventions and/or medications are typically prescribed for the treatment of type 2 diabetes, and more recently, bariatric surgery has also become part of a potential treatment plan.
During any type of physical activity (PA), glucose uptake into active skeletal muscles increases through insulin-independent pathways.
Blood glucose levels are maintained by glucoregulatory hormone-derived increases in hepatic glucose production and free fatty acid mobilization, which can be affected by insulin resistance or diabetes. Improvements in systemic, and possibly hepatic, insulin sensitivity after any PA can last from 2 to 72 h, with reductions in blood glucose closely associated with the duration and intensity of PA.
Additionally, regular PA improves β-cell function, insulin sensitivity, vascular function, and gut microbiota, all of which can lead to better diabetes control as well as risk reduction.
Consensus statements and recommendations
|